BioSpace News Archive

Business

Biostage Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2021 Financial Results

Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), today announced that it will be hosting a conference call to discuss fourth quarter and full year financial results.

March 30, 2022
·
3 min read
Business

LifeTech Scientific Corporation (1302.HK) Announces 2021 Annual Results

LifeTech Scientific Corporation, a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, announced 2021 annual results.

March 30, 2022
·
4 min read
Business

Metacrine Reports Fourth-Quarter 2021 Results

Metacrine, Inc., a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal diseases, reported its fourth-quarter 2021 financial results.

March 30, 2022
·
5 min read
Business

Miromatrix Reports Fourth Quarter and Full Year 2021 Results and Provides Corporate Update

Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today reported fourth quarter and full year 2021 financial results and provided a corporate update.

March 30, 2022
·
10 min read
Drug Development

Relacorilant Plus Nab-Paclitaxel Extends Survival in Women with Recurrent, Platinum-resistant Ovarian Cancer

Corcept Therapeutics Incorporated (NASDAQ: CORT), today announced overall survival (“OS”) data from its 178-patient, randomized, controlled, Phase 2 study of relacorilant plus nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer

March 30, 2022
·
11 min read
Business

RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Preliminary First Quarter 2022 UPNEEQ® Revenue Estimate and Business Update

RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced financial results and business highlights for the three months and full year ended December 31, 2021.

March 30, 2022
·
23 min read
BioCapital

Processa Pharmaceuticals Announces Year-End 2021 Results and Provides Corporate Update

Processa Pharmaceuticals, Inc. announced financial results for the year ended December 31, 2021, and provided a corporate update.

March 30, 2022
·
6 min read
Business

Angion Provides Corporate Update and Reports Full Year 2021 Financial Results

Angion Biomedica Corp. (NASDAQ:ANGN), a biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, today reported its financial results for full year 2021.

March 30, 2022
·
9 min read
BioMidwest

Change of Composition of the Telix Board of Directors

Telix Pharmaceuticals Limited announces that Tiffany Olson has been appointed to the Board, as a U.S.-based independent, Non-Executive Director.

March 30, 2022
·
6 min read
Business

Amylyx Pharmaceuticals Reports Full Year 2021 Financial Results

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today reported financial results for the full year ended December 31, 2021.

March 30, 2022
·
10 min read